Drreddys Laboratories | Ativos

Assets Alterar Data
ANI Pharmaceuticals USD 914.52M 10.1M 2024-03
Aurora Cannabis CAD 817.17M 1.2M 2023-12
Bayer EUR 119.88B 3.62B 2024-03
Canopy Growth CAD 1.3B 59.42M 2024-03
Catalent USD 9.88B 109M 2024-03
Cipla INR 327.18B 13.41B 2024-03
Corcept Therapeutics USD 655.94M 34.42M 2024-03
Drreddys Laboratories INR 372.84B 25.82B 2023-12
GlaxoSmithKline GBP 58.51B 494M 2024-03
Hikma Pharmaceutical USD 4.68B 61M 2023-12
Lonza CHF 16.85B 824M 2023-12
Novartis USD 94.33B 5.61B 2024-03
Pacira USD 1.58B 8.93M 2024-03
Prestige Brands USD 3.32B 21.34M 2024-03
Richter Gedeon HUF 1.26T 104.68B 2023-06
Sun Pharmaceuticals INR 854.63B 60.22B 2024-03
Supernus Pharmaceuticals USD 1.3B 26.42M 2024-03
Teva Pharmaceutical Industries USD 42.77B 706M 2024-03



Drreddys Laboratories Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jun 2024.